Recent Studies from Division of Rheumatology and Immunology Add New Data to Experimental Arthritis (Gingival mesenchymal stem cells derived from patients with rheumatoid arthritis treat experimental arthritis).

Recent studies from the Division of Rheumatology and Immunology have explored the use of gingival mesenchymal stem cells (GMSCs) derived from patients with rheumatoid arthritis (RA) to treat experimental arthritis. The research compared the therapeutic efficacy of RA-GMSCs and healthy donor-derived GMSCs, showing that RA-GMSCs were as effective in suppressing inflammation and had a robust therapeutic effect on arthritis models. The study suggests that manipulating RA-GMSCs may have therapeutic potential for RA patients in the future. [Extracted from the article]

Copyright of Stem Cell Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)